Page 2483 - Williams Hematology ( PDFDrive )

2454 Index Index 2455

Interleukin (IL)-1 in hematopoietic stem cells, 264t in neutrophils, 932, 1008
aplastic anemia and, 519, 526 in inflammatory response, 1978 T cells and, 1182
FH
in disseminated intravascular coagulation, lymphoma and, 1573 Th cells and, 1180
2200, 2202 in lymphopoiesis, 1154 in vaccine therapy, 422
in familial Mediterranean fever, 1025 macrophage activation and, 1070t, Interleukin (IL)-11
fibrinolysis and, 2202 1085–1086 in hematopoietic stem cells, 264t
hematopoiesis and, 258f in macrophages, 1064, 1066 in megakaryopoiesis, 1821
in hematopoietic stem cells, 264t monocytes and, 1046 for thrombocytopenia, 1824
in inflammation, 287–288, 287t in neutrophils, 932 Interleukin (IL)-12
in inflammatory response, 1978 T cells and, 1182 immunodeficiencies and, 1230
FH
interleukin-6 production and, 2036 Th cells and, 1180 in innate immune response, 303
matrix association, 62t in vaccine therapy, 422 monocytopenia and, 1091
monocytopenia and, 1091 Interleukin (IL)-5, 264t, 947, 949, 950, 951 mycobacterial disease and, 1231
in neutrophils, 932, 934 Interleukin (IL)-5Rα, 1141 in neutrophils, 933t
Interleukin (IL)-1α, 303 Interleukin (IL)-6 Th cells and, 1180
Interleukin (IL)-1β in Castleman disease, 1249–1250 Interleukin (IL)-12p40 deficiency, 1231
in disseminated intravascular coagulation, in disseminated intravascular coagulation, Interleukin (IL)-12R, 1231
2208 2200, 2201, 2208 Interleukin (IL)-12Rβ deficiency, 1231
1
in inflammation, 281, 282, 284, 287–288 in heat stroke, 2209 Interleukin (IL)-13
in innate immune response, 303 in hematopoietic stem cells, 264t basophil-derived, 968
in neutrophils, 932, 933t hepcidin and, 551, 552, 620 in basophils, 932
in primary myelofibrosis, 1325 in Hodgkin lymphoma, 1610 macrophage activation and, 1070t,
in sickle cell disease, 765 in inflammation, 284, 288 1085–1086
Th17 T cells and, 1182 in innate immune response, 303 Interleukin (IL)-15
Interleukin-1-β-converting enzyme-protease in large granular leukocytic leukemia, 1203 in hematopoietic stem cells, 264t
activating factor (Ipaf), 1066f in megakaryopoiesis, 1821 in neutrophils, 932, 934
Interleukin (IL)-2, 264t monocytopenia and, 1091 in vaccine therapy, 422
for acute myelogenous leukemia, 1404 in myeloma, 1709, 1759 Interleukin (IL)-15R, 1154
in aplastic anemia, 515 in neutrophils, 933t Interleukin (IL)-17, 1182
in cellular therapy, 412 in primary myelofibrosis, 1325 Interleukin (IL)-21, 264t, 1154, 1172, 1699
in large granular leukocytic leukemia, 1203 in sickle cell disease, 765 Interleukin (IL)-22, 1182, 1699
in lymphopoiesis, 1154 in thrombopoiesis, 2035–2036 Interleukin (IL)-23, 1182
T-cell receptors and, 1178, 1181 Interleukin (IL)-6 receptor family, 247–248, Interleukin receptor-associated kinase
in vaccine therapy, 422 248f (IRAK), 298
Interleukin (IL)-2R, 1154 Interleukin (IL)-7 Interleukin receptor-associated kinase
Interleukin (IL)-2Rα, 1700 in hematopoiesis, 258f (IRAK)-4 deficiency, 1054, 1230
Interleukin (IL)-2 receptor antibody. See in hematopoietic stem cells, 264t Interlineal leukemia, 1386
Daclizumab in lymphopoiesis, 270, 1154 International normalized ratio (INR),
Interleukin (IL)-2 receptor family, 248f, 249 in severe combined immune deficiency, 395–396, 396t
Interleukin (IL)-3 1217 Intestinal disorders. See Gastrointestinal tract
basophils and, 966 Interleukin (IL)-7Rα, 1154, 1214t disorders
BCR-ABL1 and, 1441 Interleukin (IL)-8 (neutrophil-activating Intraarterial thrombolysis, 2315–2316
BFU-E and, 483f peptide 1) Intracranial hemorrhage, 2119, 2123, 2315
for Diamond-Blackfan anemia, 540 in disseminated intravascular coagulation, Intramembrane particles (IMPs), 1047
eosinophils and, 947, 949 2208 Intraocular lymphoma, 1580–1581
hematopoiesis and, 258f in heat stroke, 2209 Intravascular large B-cell lymphoma, 1496t,
in hematopoietic stem cells, 264t lymphoma and, 1573 1626, 1635–1636
in inflammatory response, 1978 in neutrophils, 288t, 932, 1007, 1007f, 1844 Intravenous immunoglobulin (IVIg)
in megakaryopoiesis, 1817, 1821 Interleukin (IL)-9, 264t, 950, 1154 for acquired von Willebrand disease, 2082
in myeloma, 1713 Interleukin (IL)-10 for agammaglobulinemia, 1213
neutrophilic granulopoiesis and, 940 in Hodgkin lymphoma, 1607, 1610, 1617 for alloimmune hemolytic disease of the
Interleukin (IL)-4 lymphoma and, 1573 fetus and newborn, 857–858
basophil-derived, 968 macrophage activation and, 1086 for antiphospholipid syndrome in
in basophils, 932 macrophage deactivation and, 1070t pregnancy, 2245
in eosinophils, 950, 952 monocytes and, 1091 for aplastic anemia, 527
hematopoiesis and, 258f monocytosis and, 1097 for autoimmune hemolytic anemia, 838

Kaushansky_index_p2393-2506.indd 2454 9/21/15 3:22 PM